Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins

Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate

(2014) Henrik Leonhardt et al.   FERTILITY AND STERILITY

Ovarian volume and antral follicle count assessed by MRI and transvaginal ultrasonography: a methodological study

(2013) Henrik Leonhardt et al.   ACTA RADIOLOGICA

Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial

(2013) Åsa Nybacka et al.   FERTILITY AND STERILITY

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp

(2013) N. K. Stepto et al.   HUMAN REPRODUCTION

Can Anti-Müllerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data

(2013) Stamatina Iliodromiti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Measurement of Anti-Müllerian Hormone: A Critical Appraisal

(2013) Oybek Rustamov et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia

(2012) Jacqueline A Boyle et al.   MEDICAL JOURNAL OF AUSTRALIA

Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?

(2011) Piotr Skałba et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Exercise Decreases Anti-Müllerian Hormone in Anovulatory Overweight Women with Polycystic Ovary Syndrome – A Pilot Study

(2011) L. Moran et al.   HORMONE AND METABOLIC RESEARCH

Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries

(2011) D. Dewailly et al.   HUMAN REPRODUCTION

The Metabolic Status Modulates the Effect of Metformin on the Antimullerian Hormone-Androgens-Insulin Interplay in Obese Women with Polycystic Ovary Syndrome

(2011) D. Romualdi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline

(2011) Helena J Teede et al.   MEDICAL JOURNAL OF AUSTRALIA

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

(2010) Lisa J. Moran et al.   HUMAN REPRODUCTION UPDATE

Effects of Exercise on Insulin Resistance and Body Composition in Overweight and Obese Women with and without Polycystic Ovary Syndrome

(2010) Samantha K. Hutchison et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Development of a second generation anti-Müllerian hormone (AMH) ELISA

(2010) Ajay Kumar et al.   JOURNAL OF IMMUNOLOGICAL METHODS

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

Anti-Mullerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome

(2009) S.M. Carlsen et al.   HUMAN REPRODUCTION

Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels

(2008) Athanasia Piouka et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

(2008) Evanthia Diamanti-Kandarakis   EXPERT REVIEWS IN MOLECULAR MEDICINE

Müllerian-inhibiting substance inhibits cytochrome P450 aromatase activity in human granulosa lutein cell culture

(2007) Michael P. Grossman et al.   FERTILITY AND STERILITY